Incidence, characteristics, and survival of patients with EGFR-mutant lung cancers with EGFR T790M at diagnosis identified in the lung cancer mutation consortium (LCMC).
Year: 2013
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Mark G. Kris, Geoffrey R. Oxnard, Bruce E. Johnson, Lynne D Berry, Heidi Chen, David J. Kwiatkowski, Anthony John Iafrate, Ignacio Ivan Wistuba, Wilbur A. Franklin, Dara Aisner, Lecia V. Sequist, Fadlo Raja Khuri, Edward B. Garon, William Pao, Charles M. Rudin, Joan H. Schiller, Eric B. Haura, John D. Minna, Paul A. Bunn
Institutions: Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Harvard University, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, University of Colorado Denver, University of Colorado Anschutz, Emory University, Winship Cancer Institute, University of California, Los Angeles, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Moffitt Cancer Center, University of Colorado Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2602675802